Investors Hangout Stock Message Boards Logo
  • Mailbox
  • Favorites
  • Boards
    • The Hangout
    • NASDAQ
    • NYSE
    • OTC Markets
    • All Boards
  • Whats Hot!
    • Recent Activity
    • Most Viewed Boards
    • Most Viewed Posts
    • Most Posted
    • Most Followed
    • Top Boards
    • Newest Boards
    • Newest Members
  • Blog
    • Recent Blog Posts
    • Recently Updated
    • News
    • Stocks
    • Crypto
    • Investing
    • Business
    • Markets
    • Economy
    • Real Estate
    • Personal Finance
  • Market Movers
  • Interactive Charts
  • Login - Join Now FREE!
  1. Home ›
  2. Stock Message Boards ›
  3. Stock Boards ›
  4. CytoDyn Inc (CYDY) Message Board

The global chemotherapy market was valued at USD 9

Message Board Public Reply | Private Reply | Keep | Replies (1)                   Post New Msg
Edit Msg () | Previous | Next


Post# of 155555
(Total Views: 820)
Posted On: 06/08/2025 5:54:13 PM
Posted By: My69z
The global chemotherapy market was valued at USD 9.55 billion in 2024 and is projected to reach USD 19.87 billion by 2034, according to Statifacts.

The global radiation oncology market size was exhibited at USD 9.75 billion in 2023 and is projected to hit around USD 31.66 billion by 2033

The global PARP Inhibitors Market was valued at approximately USD 7.9 billion in 2023 and is projected to reach USD 8.4 billion in 2024. By 2033, the market is expected to reach about USD 23.5 billion

The CAR T-Cell therapy market size is calculated at $8.46 bn in 2025 is to hit $88.51 bn by 2034.

The global immune checkpoint inhibitor market is projected to reach $189.3 billion by 2032, growing at a CAGR of 16.8%. Key drivers include the increasing prevalence of cancer, the efficacy of ICIs in various cancer types, and expanding indications. The market is segmented by type (PD-1, PD-L1, CTLA-4), application (lung cancer, melanoma, etc.), and geography (North America, Asia-Pacific, etc.).
____

@ end of our website video on these 5 Synergestic MOA's, recent ICI news & it's another $325b potentially effected by LL.


(7)
(0)




CytoDyn Inc (CYDY) Stock Research Links


  1.  
  2.  


  3.  
  4.  
  5.  






Investors Hangout

Home

Mailbox

Message Boards

Favorites

Whats Hot

Blog

Settings

Privacy Policy

Terms and Conditions

Disclaimer

Contact Us

Whats Hot

Recent Activity

Most Viewed Boards

Most Viewed Posts

Most Posted Boards

Most Followed

Top Boards

Newest Boards

Newest Members

Investors Hangout Message Boards

Welcome To Investors Hangout

Stock Message Boards

American Stock Exchange (AMEX)

NASDAQ Stock Exchange (NASDAQ)

New York Stock Exchange (NYSE)

Penny Stocks - (OTC)

User Boards

The Hangout

Private

Global Markets

Australian Securities Exchange (ASX)

Euronext Amsterdam (AMS)

Euronext Brussels (BRU)

Euronext Lisbon (LIS)

Euronext Paris (PAR)

Foreign Exchange (FOREX)

Hong Kong Stock Exchange (HKEX)

London Stock Exchange (LSE)

Milan Stock Exchange (MLSE)

New Zealand Exchange (NZX)

Singapore Stock Exchange (SGX)

Toronto Stock Exchange (TSX)

Contact Investors Hangout

Email Us

Follow Investors Hangout

Twitter

YouTube

Facebook

Market Data powered by QuoteMedia. Copyright © 2025. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges).
Analyst Ratings & Earnings by Zacks. RT=Real-Time, EOD=End of Day, PD=Previous Day. Terms of Use.

© 2025 Copyright Investors Hangout, LLC All Rights Reserved.

Privacy Policy |Do Not Sell My Information | Terms & Conditions | Disclaimer | Help | Contact Us